CTX310 showed promising safety and efficacy in a small Phase I trial, according to data presented at the American Heart ...
The approach is “very exciting,” but one expert says a lot more research is needed, especially around safety, before clinical ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback